High costs and burden of illness in acute rhinosinusitis: Real-life treatment patterns and outcomes in Swedish primary care

Primary Care Respiratory Journal

Volumn 21, Issue 2, 2012, Pages 174-179

  Stjärne, Pär ^a   Odebäck, Peter ^b   Ställberg, Björn ^c   Lundberg, Johan ^d   Olsson, Petter ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b Skagern Primary Health Care Centre   (Sweden)

^c UPPSALA UNIVERSITY   (Sweden)

^d Outcomes Research   (Sweden)

Author keywords

Adults; EQ 5D ; Major Symptom Score; Observational study; Primary care; Rhinosinusitis; Visual analogue scale

Indexed keywords

ANALGESIC AGENT; ANTIBIOTIC AGENT; ANTIHISTAMINIC AGENT; CORTICOSTEROID; DECONGESTIVE AGENT;

ACUTE RHINOSINUSITIS; ADULT; AGED; ARTICLE; DISEASE SEVERITY; FEMALE; FOLLOW UP; HEALTH CARE COST; HELP SEEKING BEHAVIOR; HUMAN; MAJOR CLINICAL STUDY; MAJOR SYMPTOM SCORE; MALE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PAIN; PRESCRIPTION; PRIMARY MEDICAL CARE; PROSPECTIVE STUDY; QUALITY OF LIFE; SCORING SYSTEM; SWEDEN; VISUAL ANALOG SCALE;

ACUTE DISEASE; ADMINISTRATION, INTRANASAL; ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; AGED; AGED, 80 AND OVER; COST OF ILLNESS; FEMALE; HEALTH CARE COSTS; HUMANS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PHYSICIAN'S PRACTICE PATTERNS; QUALITY OF LIFE; QUESTIONNAIRES; RHINITIS; SINUSITIS; SWEDEN; YOUNG ADULT;

EID: 84862683104     PISSN: 14714418     EISSN: 14751534     Source Type: Journal    
DOI: 10.4104/pcrj.2012.00011     Document Type: Article

References (25)

1. Lindbaek M. Acute sinusitis: guide to selection of antibacterial therapy. Drugs 2004;64(8):805-19. http://dx.doi.org/10.2165/00003495-200464080-00002
2. Slavin RG, Spector SL, Bernstein IL, et al. The diagnosis and management of sinusitis: a practice parameter update. J Allergy Clin Immunol 2005;116(6 Suppl):S13-S47. http://dx.doi.org/10.1016/j.jaci.2005.09.048
3. Sande MA and Gwaltney JM. Acute community-acquired bacterial sinusitis: continuing challenges and current management. Clin Infect Dis 2004;39(Suppl 13):S151-8. http://dx.doi.org/10.1086/421353.
4. Fokkens W, Lund V, Mullol J. European position paper on rhinosinusitis and nasal polyps. Rhinol Suppl 2007;20:1-136.
5. Thomas M, Yawn BP, Price D, Lund V, Mullol J, Fokkens W. EPOS Primary Care Guidelines: European position paper on the primary care diagnosis and management of rhinosinusitis and nasal polyps 2007-a summary. Prim Care Respir J 2008;17(2):79-89. http://dx.doi.org/10.3132/pcrj.2008.00029.
6. Hickner JM. Acute rhinosinusitis: a diagnostic and therapeutic challenge. J Fam Pract 2001;50(1):38-40.
7. Piccirillo JF. Clinical practice. Acute bacterial sinusitis. N Engl J Med 2004;351(9):902-10. http://dx.doi.org/10.1056/NEJMcp035553.
8. Anon JB, Jacobs MR, Poole MD, et al. Antimicrobial treatment guidelines for acute bacterial rhinosinusitis. Otolaryngol Head Neck Surg 2004;130(1 Suppl):1-45. http://dx.doi.org/10.1016/j.otohns.2003.12.003
9. Stalman W, van Essen GA, van der Graaf Y, de Melker RA. The end of antibiotic treatment in adults with acute sinusitis-like complaints in general practice? A placebo-controlled double-blind randomized doxycycline trial. Br J Gen Pract 1997;47(425):794-9.
10. Meltzer EO, Bachert C, Staudinger H. Treating acute rhinosinusitis: comparing efficacy and safety of mometasone furoate nasal spray, amoxicillin, and placebo. J Allergy Clin Immunol 2005;116(6):1289-95. http://dx.doi.org/10.1016/ j.jaci.2005.08.044.
11. Young J, De Sutter A, Merenstein D, et al. Antibiotics for adults with clinically diagnosed acute rhinosinusitis: a meta-analysis of individual patient data. Lancet 2008;371(9616):908-14. http://dx.doi.org/10.1016/S0140-6736(08)60416-X.
12. Felmingham D, Reinert RR, Hirakata Y, Rodloff A. Increasing prevalence of antimicrobial resistance among isolates of Streptococcus pneumoniae from the PROTEKT surveillance study, and comparative in vitro activity of the ketolide, telithromycin. J Antimicrob Chemother 2002;50(Suppl S1):25-37.
13. Ashworth M, Charlton J, Ballard K, Latinovic R, Gulliford M. Variations in antibiotic prescribing and consultation rates for acute respiratory infection in UK general practices 1995-2000. Br J Gen Pract 2005;55(517):603-08.
14. Berg O, Carenfelt C, Kronvall G. Bacteriology of maxillary sinusitis in relation to character of inflammation and prior treatment. Scand J Infect Dis 1988;20(5):511-16. http://dx.doi.org/10.3109/00365548809032499
15. Hoffmans R, Schermer T, van Weel C, Fokkens W. Management of rhinosinusitis in Dutch general practice. Prim Care Respir J 2011;20(1):64-70. http://dx.doi.org/10.4104/pcrj.2010.00064.
16. Bachert C, Meltzer EO. Effect of mometasone furoate nasal spray on quality of life of patients with acute rhinosinusitis. Rhinology 2007;45(3):190-6.
17. Revicki D, Margolis M, Thompson C, Meltzer E, Sandor D, Shaw J. Major Symptom Score Utility Index for patients with acute rhinosinusitis. Am J Rhinol Allergy 2011;25(3):99-106. http://dx.doi.org/10.2500/ajra.2011.11.3575.
18. Rabin R, de Charro F. EQ-5D: a measure of health status from the EuroQol Group. Ann Med 2001;33(5):337-43. http://www.euroqol.org. http://dx.doi.org/10.3109/ 07853890109002087
19. Klossek JM, Mesbah K. Presentation and treatment of acute maxillary sinusitis in general practice: a French observational study. Rhinology 2011;49(1):84-9.
20. Mölstad S, Erntell M, Hanberger H, et al. Sustained reduction of antibiotic use and low bacterial resistance: 10-year follow-up of the Swedish Strama programme. Lancet Infect Dis 2008;8(2):125-32. http://dx.doi.org/10.1016/S1473-3099(08)70017-3.
21. Ahovuo-Saloranta A, Borisenko OV, Kovanen N, et al. Antibiotics for acute maxillary sinusitis. Cochrane Database Syst Rev 2008;(2):CD000243. http://dx.doi.org/10.1002/14651858.CD000243.pub2.
22. Meltzer EO, Hamilos DL, Hadley JA, et al. Rhinosinusitis: establishing definitions for clinical research and patient care. J Allergy Clin Immunol 2004;114(6 suppl):155-212. http://dx.doi.org/10.1016/j.jaci.2004.09.029.
23. Jansson SA, Rönmark E, Forsberg B, Löfgren C, Lindberg A, Lundbäck B. The economic consequences of asthma among adults in Sweden. Respir Med 2007;101(11):2263-70. http://dx.doi.org/10.1016/j.rmed.2007.06.029.
24. Gendo K, Sullivan SD, Lozano P, Finkelstein JA, Fuhlbrigge A, Weiss KB. Resource costs for asthma-related care among pediatric patients in managed care. Ann Allergy Asthma Immunol 2003;91(3):251-7. http://dx.doi.org/10.1016/S1081-1206(10)63526-0.
25. Hellgren J, Cervin A, Nordling S, Bergman A, Cardell LO. Allergic rhinitis and the common cold-high cost to society. Allergy 2010;65(6):776-83. http://dx.doi.org/10.1111/j.1398-9995.2009.02269.x.